Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2Cl.Co |
| Molecular Weight | 130.84 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[60Co++]
InChI
InChIKey=GVPFVAHMJGGAJG-FCHARDOESA-L
InChI=1S/2ClH.Co/h2*1H;/q;;+2/p-2/i;;1+1
| Molecular Formula | Co |
| Molecular Weight | 59.933822196 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cobaltous chloride Co-60 is a gamma emitter used in nuclear medicine in the form of high specific activity sources. Co-60 brachytherapy is used to treat carcinoma of the uterine cervix, the second most common cancer in women and the most common cause of death in cancer patients in the developing countries. Co-60 high dose rate brachytherapy unit is a good choice especially for the centers with a small number of brachytherapy procedures. Co-60 demonstrates cost-favorability in Peru and may similarly in other locations.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroad. | 2018-12 |
|
| Dosimetric study of CO-60 source step size in uterine cervix intracavitary HDR brachytherapy. | 2018-07-19 |
|
| Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60). | 2017-11 |
Sample Use Guides
The retrospective study is based on data of 15 patients of carcinoma cervix (Ca-cx) treated with Co-60 high-dose-rate intracavitary brachytherapy with dose of 21 Gy in three fractions with source step size of 2.5 mm after external beam radiotherapy of 46 Gy.
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:32 GMT 2025
by
admin
on
Mon Mar 31 18:10:32 GMT 2025
|
| Record UNII |
7812FUQ8VK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1446
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
14543-09-0
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY | |||
|
SUB22662
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY | |||
|
100000092340
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY | |||
|
DTXSID30163011
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY | |||
|
66372
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY | |||
|
7812FUQ8VK
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL1909055
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY | |||
|
C76277
Created by
admin on Mon Mar 31 18:10:32 GMT 2025 , Edited by admin on Mon Mar 31 18:10:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
